Collector
Two shots, maximum protection - Nigeria launches revolutionary HIV injection programme in Abuja, eyes zero infections by 2030 | Collector and may even be injurious to your health," she added. Dr. Fasawe noted that while the program prioritises high-risk groups and discordant couples, the drug is 'really for everyone' who tests negative. "The reason why I decided to go for the injection is because I hardly take the tablets. Sometimes I forget to take the tablets," said Lyka Ojolaku, one of the first recipients in Abuja. "I just feel like taking the injection is better. After taking it, you rest for six months before taking another one. So I prefer this; it is better for me than taking the tablets," he added. Lenacapavir is a first-of-its-kind 'capsid inhibitor' that blocks the virus from entering cells. Developed by Gilead Sciences, it is considered the most powerful HIV shield to date. Nigeria aims to overcome its high HIV burden and daily pill adherence failures by introducing twice-yearly injections, a strategy designed to bypass social stigma and reach zero new infections by 2030.""> and may even be injurious to your health," she added. Dr. Fasawe noted that while the program prioritises high-risk groups and discordant couples, the drug is 'really for everyone' who tests negative. "The reason why I decided to go for the injection is because I hardly take the tablets. Sometimes I forget to take the tablets," said Lyka Ojolaku, one of the first recipients in Abuja. "I just feel like taking the injection is better. After taking it, you rest for six months before taking another one. So I prefer this; it is better for me than taking the tablets," he added. Lenacapavir is a first-of-its-kind 'capsid inhibitor' that blocks the virus from entering cells. Developed by Gilead Sciences, it is considered the most powerful HIV shield to date. Nigeria aims to overcome its high HIV burden and daily pill adherence failures by introducing twice-yearly injections, a strategy designed to bypass social stigma and reach zero new infections by 2030.""> and may even be injurious to your health," she added. Dr. Fasawe noted that while the program prioritises high-risk groups and discordant couples, the drug is 'really for everyone' who tests negative. "The reason why I decided to go for the injection is because I hardly take the tablets. Sometimes I forget to take the tablets," said Lyka Ojolaku, one of the first recipients in Abuja. "I just feel like taking the injection is better. After taking it, you rest for six months before taking another one. So I prefer this; it is better for me than taking the tablets," he added. Lenacapavir is a first-of-its-kind 'capsid inhibitor' that blocks the virus from entering cells. Developed by Gilead Sciences, it is considered the most powerful HIV shield to date. Nigeria aims to overcome its high HIV burden and daily pill adherence failures by introducing twice-yearly injections, a strategy designed to bypass social stigma and reach zero new infections by 2030."">
Two shots, maximum protection - Nigeria launches revolutionary HIV injection programme in Abuja, eyes zero infections by 2030
Ruptly

Two shots, maximum protection - Nigeria launches revolutionary HIV injection programme in Abuja, eyes zero infections by 2030

"Nigeria has officially rolled out Lenacapavir, a groundbreaking twice-yearly injection that transitions the nation's HIV prevention strategy from daily pills to a bi-annual regimen, providing maximum protection. Footage from the launch in Abuja shows the first citizens receiving the long-acting dose during an event held under the slogan 'Flagging off the future of HIV prevention'. "Lenacapavir is long-acting and is for the prevention of HIV/AIDS," stated Dr. Adedolapo Fasawe, the FCT Mandate Secretary for Health and Environment. "Across all populations, the first thing we check for is to ensure you're HIV negative. If you're positive, the medicine doesn't work. It's just a waste of resources <...> and may even be injurious to your health," she added. Dr. Fasawe noted that while the program prioritises high-risk groups and discordant couples, the drug is 'really for everyone' who tests negative. "The reason why I decided to go for the injection is because I hardly take the tablets. Sometimes I forget to take the tablets," said Lyka Ojolaku, one of the first recipients in Abuja. "I just feel like taking the injection is better. After taking it, you rest for six months before taking another one. So I prefer this; it is better for me than taking the tablets," he added. Lenacapavir is a first-of-its-kind 'capsid inhibitor' that blocks the virus from entering cells. Developed by Gilead Sciences, it is considered the most powerful HIV shield to date. Nigeria aims to overcome its high HIV burden and daily pill adherence failures by introducing twice-yearly injections, a strategy designed to bypass social stigma and reach zero new infections by 2030."

Go to News Site